| Issue Date | Title | Author(s) |
| 2018-12-01 | A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer | Matin, F; Jeet, V; Moya, L; Selth, LA; Chambers, S; Clements, JA; Batra, J; Yeadon, T; Saunders, P; Eckert, A; Heathcote, P; Wood, G; Malone, G; Samaratunga, H; Collins, A; Turner, M; Kerr, K |
| 2012-12-01 | EXPRESSION OF P21 IS DEPENDENT ON OR INDEPENDENT OF P53 IN CARCINOMA EX PLEOMORPHIC ADENOMA (UNDIFFERENTIATED AND ADENOCARCINOMA TYPES) | Tarakji, B; Baroudi, K; Hanouneh, S; Nassani, MZ; Alotaibi, AM; Kharma, MY; Azzeghaiby, SN |
| 2021-11 | A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. | Bancroft, EK; Page, EC; Brook, MN; Thomas, S; Taylor, N; Pope, J; McHugh, J; Jones, A-B; Karlsson, Q; Merson, S; Ong, KR; Hoffman, J; Huber, C; Maehle, L; Grindedal, EM; Stormorken, A; Evans, DG; Rothwell, J; Lalloo, F; Brady, AF; Bartlett, M; Snape, K; Hanson, H; James, P; McKinley, J; Mascarenhas, L; Syngal, S; Ukaegbu, C; Side, L; Thomas, T; Barwell, J; Teixeira, MR; Izatt, L; Suri, M; Macrae, FA; Poplawski, N; Chen-Shtoyerman, R; Ahmed, M; Musgrave, H; Nicolai, N; Greenhalgh, L; Brewer, C; Pachter, N; Spigelman, AD; Azzabi, A; Helfand, BT; Halliday, D; Buys, S; Ramon Y Cajal, T; Donaldson, A; Cooney, KA; Harris, M; McGrath, J; Davidson, R; Taylor, A; Cooke, P; Myhill, K; Hogben, M; Aaronson, NK; Ardern-Jones, A; Bangma, CH; Castro, E; Dearnaley, D; Dias, A; Dudderidge, T; Eccles, DM; Green, K; Eyfjord, J; Falconer, A; Foster, CS; Gronberg, H; Hamdy, FC; Johannsson, O; Khoo, V; Lilja, H; Lindeman, GJ; Lubinski, J; Axcrona, K; Mikropoulos, C; Mitra, AV; Moynihan, C; Ni Raghallaigh, H; Rennert, G; Collier, R; IMPACT Study Collaborators,; Offman, J; Kote-Jarai, Z; Eeles, RA |
| 2016-09 | Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol. | Roberts, MJ; Yaxley, JW; Coughlin, GD; Gianduzzo, TRJ; Esler, RC; Dunglison, NT; Chambers, SK; Medcraft, RJ; Chow, CWK; Schirra, HJ; Richards, RS; Kienzle, N; Lu, M; Brereton, I; Samaratunga, H; Perry-Keene, J; Payton, D; Oyama, C; Doi, SA; Lavin, MF; Gardiner, RA |
| 2017-08 | Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. | Najdawi, F; Crook, A; Maidens, J; McEvoy, C; Fellowes, A; Pickett, J; Ho, M; Nevell, D; McIlroy, K; Sheen, A; Sioson, L; Ahadi, M; Turchini, J; Clarkson, A; Hogg, R; Valmadre, S; Gard, G; Dooley, SJ; Scott, RJ; Fox, SB; Field, M; Gill, AJ |
| 2020-05-01 | Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer. | Butow, P; Davies, G; Napier, CE; Schlub, T; Best, MC; Bartley, N; Juraskova, I; Meiser, B; Ballinger, ML; Biesecker, B; Goldstein, D; Thomas, DM; PiGeOn Project, |
